会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Networked document partially printing system and method
    • 网络文件部分打印系统和方法
    • US20060095436A1
    • 2006-05-04
    • US11258893
    • 2005-10-27
    • Yoshihiko Abe
    • Yoshihiko Abe
    • G06F17/30
    • G06F16/95G06F2216/17
    • A networked printing system includes an electronic document server having a database that stores a plurality of electronic documents of books, which are uniquely identified by a plurality of identification codes, respectively. The electronic document server specifies and allows downloading of a prescribed electronic document matched with an identification code received. A transmitting device is provided to transmit a request for a prescribed electronic document and a corresponding identification code to the electronic document server via a network. A printing device connected to the electronic server document prints a portion of the electronic document in accordance with designation of pages.
    • 网络打印系统包括具有数据库的电子文档服务器,该数据库分别存储由多个识别代码唯一标识的多本书籍的电子文档。 电子文件服务器指定并允许下载与所接收的识别码相匹配的规定的电子文档。 提供发送装置,经由网络向电子文档服务器发送规定的电子文档的请求和对应的识别码。 连接到电子服务器文档的打印设备根据页面的指定打印电子文档的一部分。
    • 7. 发明授权
    • Glucose free, stable dry analytical element for quantitative analysis of
creatine kinase MB isozyme
    • 不含葡萄糖,稳定的干燥分析元素用于定量分析肌酸激酶MB同功酶
    • US05998158A
    • 1999-12-07
    • US158484
    • 1998-09-22
    • Hideaki TanakaYoshihiko AbeKaoru Terashima
    • Hideaki TanakaYoshihiko AbeKaoru Terashima
    • C12Q1/50
    • C12Q1/50
    • A dry analytical element for quantitatively analyzing creatine kinase MB isozyme is composed of a support and a creatine kinase MB isozyme-detecting agent layer. The detecting layer contains an antibody which specifically inhibits activity of M sub-unit of creatine kinase, creatine phosphate and adenosine diphosphate which react with each other to give adenosine triphosphate in the presence of creatine kinase MB isozyme, a buffer compound which keeps the layer in the range of pH 5.5 to pH 8.5 for the formation of adenosine triphosphate, and an indicator composition which reacts with the formed adenosine triphosphate to give a spectroscopically detectable compound, said indicator composition having hexokinase, nicotinamide-adenine dinucleotide or its phosphate in an oxidized form, and glucose-6-phosphate dehydrogenase but not containing glucose in such amount as to give the spectroscopically detectable compound.
    • 用于定量分析肌酸激酶MB同功酶的干燥分析元件由载体和肌酸激酶MB同工酶检测剂层组成。 检测层含有特异性抑制肌酸激酶,亚磷酸肌酸和磷酸腺苷的M亚单位的活性的抗体,其在肌酸激酶MB同功酶(一种保持该层的缓冲化合物)存在下相互反应,产生三磷酸腺苷 用于形成三磷酸腺苷的pH 5.5至pH 8.5的范围,以及与形成的三磷酸腺苷反应以产生光谱可检测化合物的指示剂组合物,所述指示剂组合物具有己糖激酶,烟酰胺 - 腺嘌呤二核苷酸或其氧化形式的磷酸酯 和葡萄糖-6-磷酸脱氢酶,但不含葡萄糖,其量使得可得到光谱可检测的化合物。
    • 9. 发明授权
    • Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material
    • 可交联的多糖衍生物,其制造方法,交联性多糖组合物和医疗处理材料
    • US07485719B2
    • 2009-02-03
    • US10546256
    • 2004-02-20
    • Yoshihiko AbeTakao Anzai
    • Yoshihiko AbeTakao Anzai
    • A61K31/728C07H13/10C07H3/06
    • C08B37/0021A61L24/08A61L31/042C08B37/003
    • A crosslinkable polysaccharide derivative which has in the side chain of polysaccharide at least one active ester group reactive with an active hydrogen-containing group and which forms a crosslinked product through covalent bond between the active ester group and the active hydrogen-containing group upon contact with alkaline water. A composition and a medical treatment material containing the crosslinkable polysaccharide derivative. The crosslinkable polysaccharide derivative produces a high bond strength that meets clinical requirements. It avoids the risk of infection because it is based on a material which is not derived from living organisms. It in itself and its decomposition products have a low level of toxicity because it is formed from a synthetic material. It is biodegradable and bioabsorbable. It can be prepared readily and simply without requiring special apparatus at the time of use.
    • 一种交联性多糖衍生物,其在多糖的侧链中具有至少一个与活性含氢基团反应的活性酯基,并且通过活性酯基和含活性氢基团之间的共价键在与 碱性水。 含有交联性多糖衍生物的组合物和医疗处理材料。 交联性多糖衍生物具有高粘合强度,能够满足临床要求。 它避免感染的风险,因为它是基于不衍生自活生物体的材料。 它本身及其分解产物的毒性低,因为它是由合成材料形成的。 它是可生物降解和生物可吸收的。 它可以容易和简单地制备,而不需要使用时的特殊装置。